Copied
 
 
Formål
Formål
Selskabets formål er at drive virksomhed inden for den farmaceutiske, biotekniske og medicinske produktionsindustri, herunder men ikke begrænset til kliniske forsøg, samt anden hermed forbundet virksomhed.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 15.12.2008 (5765 dage).
Ingen historik.
Status
Virksomhedsstatus
NORMAL.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 01.07.2008 (5932 dage).
Ingen historik.
Branche
Branche
Kombinerede administrationsserviceydelser (821100).
Sidst opdateret den 09.07.2008 og angivet som gældende fra 01.07.2008 (5932 dage).
Ingen historik.
Revision
Revisionfravalgt
false.
Sidst opdateret den 11.03.2015 og angivet som gældende fra 01.07.2008 (5932 dage).
Ingen historik.
Revisor
Revisor
RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB
Sidst opdateret den 08.07.2020 og angivet som gældende fra 29.06.2020 (1551 dage).
Form
Virksomhedsform
60.
Sidst opdateret den 01.07.2008 og angivet som gældende fra 01.07.2008 (5932 dage).
Ingen historik.
Kontakt
Ingen nuværende registrering.
Ingen historik.
Telefon
Ingen nuværende registrering.
Ingen historik.
Navne
Ingen historik.
Tegningsregel
Tegningsregel
Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 15.12.2008 (5765 dage).
Fortolkning (2 tegningsmuligheder)
1 bestyrelsesmedlem + 1 direktør
bestyrelsen
Ingen historik.
Ansatte
27.09.2024
Kapital
27.09.2024
Fra årsrapport
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB
Revisionsvirksomhedens CVR-nr.:25492145
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):Basis of opinion We conducted our audit in accordance with international standards on auditing and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the section “Auditor’s responsibilities for the audit of the financial statements”. We are independent of the company in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our Opinion.
Konklusion (revision):Opinion We have audited the financial statements of Parexel Denmark A/S for the financial year 1 January 2023 - 31 December 2023, which comprise a summary of significant accounting policies, income statement, statement of financial position, statement of changes in equity and notes. The financial statements have been prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements present a fair view of the company's assets, equity and liabilities, and financial position at 31 December 2023 and of the results of the company's activities for the financial year 1 January 2023 - 31 December 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on the Management's Review Management is responsible for the Management's review. Our opinion on the financial statements døs not cover the management commentary, and we express no assurance opinion thereon. In connection with our audit of the financial statements, it is our responsibility to read the management commentary and to consider whether the management commentary is materially inconsistent with the financial statements or the evidence obtained during the audit, or whether it otherwise appears to contain material misstatement. Furthermore, it is our responsibility to consider whether the Management’s Review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we believe that Management’s Review is consistent with the financial statements and that it has been prepared in accordance with the provisions of the Danish Financial Statement Act. We did not discover any material misstatement in the Management’s Review. , Management is responsible for the Management's review. Our opinion on the financial statements døs not cover the management commentary, and we express no assurance opinion thereon. In connection with our audit of the financial statements, it is our responsibility to read the management commentary and to consider whether the management commentary is materially inconsistent with the financial statements or the evidence obtained during the audit, or whether it otherwise appears to contain material misstatement. Furthermore, it is our responsibility to consider whether the Management’s Review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we believe that Management’s Review is consistent with the financial statements and that it has been prepared in accordance with the provisions of the Danish Financial Statement Act. We did not discover any material misstatement in the Management’s Review.
Bibranche
Bibranche
Virksomhedsrådgivning og anden rådgivning om driftsledelse.
Sidst opdateret den 09.07.2008 og angivet som gældende fra 01.07.2008 (5932 dage).
Ingen historik.
Børsnoteret
27.09.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
27.09.2024
Ingen nuværende registrering.
Ingen historik.